ARCHIVES

Study Finds Up To 12 Percent Of Specimens Misdiagnosed

This article is from The Cancer Letter archive.

Vol. 28 No. 10 | October 28, 2005

Download PDF Visit The Full Archive

Related Articles

Georgetown Sponsors Oncology Agent Development Meeting

March 21, 2003

Regulatory Approvals: FDA expanded the approved use of Cyramza to include metastatic NSCLC

December 19, 2014

NCI-Approved Clinical Trials Begun At Groups, Centers

November 30, 2007

In Brief: Livingston Completes Term On NCI Board, Appelbaum To Succeed Him as Chairman

November 12, 1999

Deborah Mayer Appointed To NCAB; Cancer Panel Plans Meetings For July 9

May 10, 1991

FDA, CMS Take Second Look at Drugs Given “Accelerated” Approval for Cancer

March 21, 2003